The local effect of intravesical Corynebacterium parvum in the dog. a preliminary study
Brisset, J.M.; Veillon, B.; Carmona, C.
Developments in Biological Standardization 38: 379-380
1977
ISSN/ISBN: 0301-5149 PMID: 608526 Document Number: 111948
High doses of C. parvum introduced in the bladder of the dog provoke changes in the submucosa. The significance and importance of these modifications should be investigated.
Document emailed within 1 workday
Related Documents
Chen, M.F.; Suzuki, H.; Yano, S. 1992: Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells Anticancer Research 12(2): 451-456Kirchner, H.; Chmielarczyk, W.; Storch, E.; Schindler, L. 1984: Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice Behring Institute Mitteilungen 74: 183-188
Watson, S.R.; Sljivić, V.S. 1976: The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum Clinical and Experimental Immunology 23(1): 149-153
Bellotti, R.; Tauriello, A.; Alzetta, A. 1978: Preliminary results of polychemiotherapy and immunostimulant treatment with Corynebacterium parvum in tumors of the breast in the postoperative phase and advanced phase Minerva Medica 69(21): 1443-1454
Kiya, K.; Toge, T.; Harada, K.; Uozumi, T.; Hattori, T. 1981: Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice Gan 72(3): 446-450
Fisher, B.; Gebhardt, M.C.; Saffer, E.A.; Fisher, E.R. 1979: Effect of Corynebacterium parvum in prevention and reversal of atrophy of the liver following portacaval shunt Surgery Gynecology and Obstetrics 149(2): 168-172
Budzyński, W. 1982: Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice Archivum Immunologiae et Therapiae Experimentalis 30(5-6): 379-384
Minton, J.P.; Rossio, J.L.; Dixon, B.; Dodd, M.C. 1976: The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer Clinical and Experimental Immunology 24(3): 441-447
Foresti, V.; Scolari, N.; Villa, A.; Parisio, E. 1989: Anatomical study of the fibrosing action of Corynebacterium parvum in malignant pleural effusion Minerva Medica 80(10): 1069-1072
Dimitrov, N.V.; Denny, T.N.; Weisman, M.F.; Cameron, D.G. 1979: Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells Journal of the National Cancer Institute 63(2): 423-426
Wolmark, N.; Fisher, B. 1974: The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice Cancer Research 34(11): 2869-2872
Fisher, B.; Gunduz, N. 1979: Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice Journal of the National Cancer Institute 62(6): 1545-1551
Medenica, R.; Girard, J.P.; Maurice, P. 1977: Clinical trial with Corynebacterium parvum Developments in Biological Standardization 38: 483-485
Zola, H. 1975: Mitogenicity of Corynebacterium parvum for mouse lymphocytes Clinical and Experimental Immunology 22(3): 514-521
Thatcher, N.; Swindell, R.; Crowther, D. 1979: Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions Clinical and Experimental Immunology 36(2): 227-236
Karakousis, C.P.; Didolkar, M.S.; Han, T. 1981: Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma Cancer Treatment Reports 65(9-10): 925-926
Douple, E.B. 1977: Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation National Cancer Institute Monograph 46: 179-184
Gatenby, P.A.; Basten, A.; Tattersall, M.H.; Fox, R.M. 1980: Autoantibodies in cancer patients given Corynebacterium parvum/levamisole immunotherapy Lancet 1(8177): 1082
Karakousis, C.P.; Didolkar, M.S.; Lopez, R.; Baffi, R.; Moore, R.; Holyoke, E.D. 1979: Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma Cancer Treatment Reports 63(11-12): 1739-1743
Warr, G.W.; Sljivić, V.S. 1974: Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum Clinical and Experimental Immunology 17(3): 519-532